170 related articles for article (PubMed ID: 3814757)
1. [Therapeutic application of sequential bone marrow biopsy in myeloma: analysis of 13 medullary biopsies].
Paule B; Médicis P; Clerc D; Bennet P; Bisson M; Massias P
Biomed Pharmacother; 1986; 40(7):261-4. PubMed ID: 3814757
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
Paule B; Quillard J; Medicis P; Bourgeois P; Grossin M; Bisson M; Kahn MF
Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
[TBL] [Abstract][Full Text] [Related]
3. Histomorphology of multiple myeloma on bone marrow biopsy.
Singhal N; Singh T; Singh ZN; Shome DK; Gaiha M
Indian J Pathol Microbiol; 2004 Jul; 47(3):359-63. PubMed ID: 16295424
[TBL] [Abstract][Full Text] [Related]
4. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
Paule B; Quillard J; Bennet P; Mariette X; Bisson M
Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
[TBL] [Abstract][Full Text] [Related]
5. [The prognostic significance of cytological study of the bone marrow in multiple myeloma].
Iakovleva SV
Ter Arkh; 2000; 72(7):48-51. PubMed ID: 10983321
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow changes following chemotherapy for multiple myeloma--a clinicopathological study of biopsy cases.
Kurihara K; Hill W; Burkhardt R; Kettner G; Hashimoto N
Nihon Ketsueki Gakkai Zasshi; 1987 Jul; 50(4):876-89. PubMed ID: 3687331
[No Abstract] [Full Text] [Related]
7. [The percentage of bone marrow plasmacytes and prognosis in multiple myeloma].
Paule B; Quillard J; Bennet P; Bisson M; Massias P
Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):969-72. PubMed ID: 3238308
[TBL] [Abstract][Full Text] [Related]
8. [Cell types in multiple myeloma: analysis of the correlation of bone marrow aspirates and biopsies according to 2 classifications].
de la Rosa Alcaide MA; Hernández Nieto L; Hernández García MT; Brito Barroso ML
Sangre (Barc); 1989 Aug; 34(4):313-4. PubMed ID: 2772787
[No Abstract] [Full Text] [Related]
9. Significance of nucleo-cytoplasmic maturation asynchrony in multiple myeloma.
Scudla V; Wiedermann B; Kodousek R; Dusek J; Kamarád V; Indrák K
Neoplasma; 1986; 33(4):483-92. PubMed ID: 3762809
[TBL] [Abstract][Full Text] [Related]
10. Significance of bone marrow fibrosis in multiple myeloma.
Subramanian R; Basu D; Dutta TK
Pathology; 2007 Oct; 39(5):512-5. PubMed ID: 17886102
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow biopsy in multiple myeloma: a clinical pathological study.
Aghai E; Avni G; Lurie M; Quitt M; Hornstein L; Froom P
Isr J Med Sci; 1988 Jun; 24(6):298-301. PubMed ID: 3403226
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
Campbell J; Seymour JF; Matthews J; Wolf M; Stone J; Juneja S
Eur J Haematol; 2006 Jun; 76(6):473-80. PubMed ID: 16529599
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
14. [Quantitative analysis of human herpes virus type 8 and expression of its genes in patients with multiple myeloma].
Dong Y; Zhu P; Ma M
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(20):1230-3. PubMed ID: 11825524
[TBL] [Abstract][Full Text] [Related]
15. Audit of bone marrow aspirates and trephine biopsies in multiple myeloma--a single centre study.
Charles KS; Winfield DA; Angel C; Goepel J
Clin Lab Haematol; 2004 Dec; 26(6):403-6. PubMed ID: 15595998
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma].
Wasser K; Moehler T; Nosas-Garcia S; Rehm C; Bartl R; Goldschmidt H; Düber C; Kauczor HU; Delorme S
Rofo; 2005 Aug; 177(8):1116-22. PubMed ID: 16021544
[TBL] [Abstract][Full Text] [Related]
18. Role of MRI for the diagnosis and prognosis of multiple myeloma.
Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
[TBL] [Abstract][Full Text] [Related]
19. Lymphoproliferative disorders in the bone marrow: histologic criteria for classification and staging.
Bartl R; Frisch B; Hoffmann-Fezer G; Burkhardt R
Haematologia (Budap); 1984; 17(2):227-46. PubMed ID: 6534830
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma with bone marrow biopsy features simulating concomitant chronic idiopathic myelofibrosis.
Schmidt U; Ruwe M; Leder LD
Nouv Rev Fr Hematol (1978); 1995; 37(2):159-63. PubMed ID: 7644355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
